Financials
- Market Capitalization 42.79 M
- Employee 17
- Founded 2018
- CEO N/A
- Website www.instilbio.com
- Headquarter New York, United States
- FIGI BBG00ZGYN521
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.03
ratio cours/chiffre d'affaires
151.55
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4195 | CELU Celularity Inc. - Class A Common Stock | 1.43 USD | -2.72% | -16.37% | +8.33% | -28.86% | 46.40 M USD | ||
| 4203 | ANVS Annovis Bio, Inc. Common Stock | 1.07 USD | -6.14% | -12.30% | -3.60% | -34.76% | 45.59 M USD | ||
| 4236 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.50 USD | -2.69% | -0.31% | -8.71% | +815.49% | 42.33 M USD | ||
| 4239 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.00 USD | -0.99% | -6.10% | -9.50% | -49.75% | 42.07 M USD |